Contemporary Trends Emerging in Epigenomics and Metabolism

Antioxidants and Redox Signaling

Volumn 29, Issue 11, 2018, Pages 1019-1022

  El Osta, Assam ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

chromatin; diabetes; diabetic nephropathy; epigenetics; metabolism; transcription

Indexed keywords

HOMEODOMAIN INTERACTING PROTEIN KINASE 2; METHYL CPG BINDING PROTEIN 2; MICRORNA; MICRORNA 25; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG;

CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN GENOME; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLIC DISORDER;

ANIMALS; CHROMATIN; DIABETES MELLITUS; EPIGENESIS, GENETIC; HUMANS; METABOLIC DISEASES;

EID: 85052987975     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2017.7473     Document Type: Review

References (9)

1. Cheng TL, Wang Z, Liao Q, Zhu Y, Zhou WH, Xu W, and Qiu Z. MeCP2 suppresses nuclear micro-RNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev Cell 28: 547-560, 2014.
2. Jeffery L and Nakielny S. Components of the DNA methylation system of chromatin control are RNA-binding proteins. J Biol Chem 279: 49479-49487, 2004.
3. Khan AW, Ziemann M, Corcoran SJ, Harikrishnan KN, Okabe J, Rafehi H, Maxwell SS, Esler MD, and El-Osta A. NET silencing by let-7i in postural tachycardia syndrome. JCI Insight 2: e90183, 2017.
4. Long SW, Ooi JY, Yau PM, and Jones PL. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci Rep 31 333-343, 2011.
5. Ma RC and Cooper ME. Genetics of diabetic kidney diseasefrom the worst of nightmares to the light of dawn? J Am Soc Nephrol 28: 389-393, 2017.
6. Martello G, Zacchigna L, Inui M, Montagner M, Adorno M, Mamidi A, Morsut L, Soligo S, Tran U, Dupont S, Cordenonsi M, Wessely O, and Piccolo S. MicroRNA control of Nodal signalling. Nature 449: 183-188, 2007.
7. Maxwell SS, Pelka GJ, Tam PP, and El-Osta A. Chromatin context and ncRNA highlight targets of MeCP2 in brain. RNA Biol 10: 1741-1757, 2013.
8. Oh HJ, Kato M, Deshpande S, Zhang E, Sadhan D, Lanting L, Wang M, and Natarajan R. Inhibition of the processing of MIR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy. Sci Rep 6: 38789, 2016.
9. Shiels PG, McGuinness D, Eriksson M, Kooman JP, and Stenvinkel P. The role of epigenetics in renal ageing. Nat Rev Nephrol 13: 471-482, 2017.